PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40627846,EML4-ALK rearrangement creates a distinctive myeloid cell-dominant immunosuppressive microenvironment in lung cancer.,2025,Yukari Nishito; Hideaki Mizuno; Yukiko Sonobe; Yoko Kayukawa; Hiroyuki Tsunoda,"Chugai Pharmaceutical Co., Ltd., Yokohama City, Japan.; Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan.; Chugai Pharmaceutical Co. Ltd., Yokohama, Kanagawa, Japan.; Chugai Pharmaceutical Co., Ltd., Kamakura, Kanagawa, Japan.",N/A
40627828,Telomere Dysfunction in Renal Tubular Epithelial Cells Leads to Kidney Fibrosis.,2025,Diego Mejías,"Confocal Microscopy Unit, Biotechnology Program, Spanish National Cancer Centre (CNIO), Melchor Fernández Almagro 3, Madrid, E-28029, Spain.",N/A
40627823,Assessing the Data Quality Dimensions of Surgical Oncology Cohorts in the ,2025,Emily Clark,"GAP Solutions, Inc, Herndon, VA.",N/A
40627813,RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).,2025,Praveen K Bommareddy; Junhong Zhu; Marcus Viana; Jeannie W Hou; Robert S Coffin,"Replimune, Inc., Woburn, MA, USA.",N/A
